Nanobiotix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!About NBTX
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.
CEOLaurent Lévy
CEOLaurent Lévy
Employees108
Employees108
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2003
Founded2003
Employees108
Employees108
NBTX Key Statistics
Market cap1.13B
Market cap1.13B
Price-Earnings ratio-29.16
Price-Earnings ratio-29.16
Dividend yield—
Dividend yield—
Average volume36.17K
Average volume36.17K
High today$23.28
High today$23.28
Low today$22.51
Low today$22.51
Open price$23.28
Open price$23.28
Volume29.26K
Volume29.26K
52 Week high$30.35
52 Week high$30.35
52 Week low$2.82
52 Week low$2.82
Stock Snapshot
As of today, Nanobiotix(NBTX) shares are valued at $22.70. The company's market cap stands at 1.13B, with a P/E ratio of -29.16.
On 2025-12-12, Nanobiotix(NBTX) stock traded between a low of $22.51 and a high of $23.28. Shares are currently priced at $22.70, which is +0.8% above the low and -2.5% below the high.
The Nanobiotix(NBTX)'s current trading volume is 29.26K, compared to an average daily volume of 36.17K.
In the last year, Nanobiotix(NBTX) shares hit a 52-week high of $30.35 and a 52-week low of $2.82.
In the last year, Nanobiotix(NBTX) shares hit a 52-week high of $30.35 and a 52-week low of $2.82.
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%